Anakinra for Persistent Respiratory Symptoms After COVID-19

We are studying whether anakinra can help patients with ongoing respiratory issues after COVID-19 improve their symptoms and immune function. This trial is for those experiencing long-term effects of the virus.

≤3 months Efficacy phase (II)Confirmation phase (III)Post-Trial Drug Access Investigational Medicines InjectionInfectious DiseasesInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Kineret

Kineret is a medicine that reduces inflammation to treat rheumatoid arthritis and some rare inflammatory conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Anakinra

Anakinra is a substance that blocks interleukin-1 to reduce inflammation in conditions such as rheumatoid arthritis and other inflammatory disorders.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Kineret

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitaetsmedizin Greifswald KöR

Abteilung für Anästhesiologie

Universitäts- und Hansestadt Greifswald, Germany

University General Hospital Of Alexandroupoli

2 nd Department of Internal Medicine

Alexandroupoli, Greece

Evangelismos S.A.

Pulmonary department

Athens, Greece

Sponsor: Hellenic Institute For The Study Of Sepsis

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.